Amgen Inc. (AMGN) Stock Valuation: P/E Ratio and Intrinsic Value
Is Amgen Inc. stock expensive or cheap? This page shows the price-earnings ratio of Amgen Inc. for the last fiscal years, the current share price, and beta and volatility as risk measures. Earnings figures come from the company's published filings (FY 2025).
Earnings basis for the valuation (FY 2025)
| Revenue | 36.75 USD bn |
|---|---|
| Net income | 7.71 USD bn |
| Net margin | 21.0 % |
How the Amgen Inc. P/E ratio is calculated
The price-earnings ratio divides the share price by earnings per share. On this page the ratio is shown per fiscal year, so you can see whether today's valuation of Amgen Inc. is above or below its own history. Beta and volatility indicate how strongly the share moves compared with the overall market.
Frequently asked questions about Amgen Inc.
What is the AMGN P/E ratio?
The P/E ratio divides the Amgen Inc. share price by earnings per share. This page shows the ratio for each of the last fiscal years, so the current valuation of AMGN can be compared with its own history.
Is Amgen Inc. stock overvalued or undervalued?
There is no single answer. A useful check is whether the current P/E of AMGN is above or below its multi-year average and how earnings, margins and revenue are developing. This page shows all of these figures from the published filings.
How can I estimate the intrinsic value of Amgen Inc.?
An intrinsic value estimate needs earnings or free cash flow, a growth assumption and a discount rate. This page provides the reported earnings basis, margins and the valuation history of AMGN as the starting point.